10x Genomics (TXG) EBT (2018 - 2026)

10x Genomics has disclosed EBT across 9 years of filings, most recently posting -$18.6 million for Q2 2026.

• In Q2 2026, EBT fell 150.4% year-over-year to -$18.6 million; the TTM figure through Jun 2026 stood at -$74.9 million (up 5.59% YoY), while the FY2025 annual figure was -$39.9 million, up 77.54% from the prior year.
• EBT came in at -$18.6 million for Q2 2026 at 10x Genomics, down from -$12.8 million in the prior quarter.
• In the past five years, EBT ranged from a high of $37.0 million in Q2 2025 to a low of -$91.7 million in Q3 2023.
• Average EBT over 5 years is -$36.7 million, with a median of -$38.6 million recorded in 2022.
• Year-over-year, EBT sank 541.0% in 2022 and surged 199.78% in 2025.
• Over 5 years, EBT stood at -$16.4 million in 2022, then sank by 183.94% to -$46.6 million in 2023, then retreated by 3.82% to -$48.4 million in 2024, then jumped by 68.6% to -$15.2 million in 2025, then declined by 22.72% to -$18.6 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$18.6 million in Q2 2026, -$12.8 million in Q1 2026, and -$15.2 million in Q4 2025.